Whole-body c-irradiation to mice causes thymic atrophy where a population of precancerous cells with mutation can be found. Thus, clonal growth and DNA changes at Bcl11b, Ikaros, Pten, Notch1 and Myc were examined in not only thymic lymphomas but also in atrophic thymuses at various times after irradiation. Clonal expansion was detected from the distinct patterns of rearrangements at the TCRb receptor locus in a fraction of atrophic thymuses at as early as 30 days after irradiation. This expansion may be in part owing to the rearranged TCRb signaling because the transfer of bone marrow cells with the rearrangement and the wild-type locus into severecombined immunodeficiency mice showed preferential growth of the rearranged thymocytes in atrophic thymus. Loss of heterozygosity (LOH) at Bcl11b and trisomy of Myc were found at high frequencies in both lymphomas and atrophic thymuses, and in contrast, LOH at Ikaros and Pten were rare in atrophic thymuses but prevalent in lymphomas. Notch1 activation was detected in lymphomas and in atrophic thymuses only at a late stage. Similar patterns of DNA changes were found in atrophic thymuses induced in Bcl11b þ /À mice. These results suggest the order of genetic changes during lymphomagenesis, Bcl11b and Myc being at the early stage; whereas Ikaros, Pten and Notch1 at the late stage.
Introduction
Cancers are the results of a series of somatic mutations, and some cases with genetic predisposition owing to inheritance of responsible mutations. Each successive mutation gives the cells a growth advantage, so that it forms an expanded clone, thus presenting a larger target for the next mutation (Vogelstein and Kinzler, 1993) . On the other hand, normal cells possess multiple defence mechanisms to prevent uncontrolled cell division. Some of these are devices within the cell, such as those that limit cell-cycle progression or induce apoptosis, whereas others are signals from surrounding tissues that prompt a cell to remain within its supportive microenvironment (Hanahan and Weinberg, 2000) . Ionizing radiation is a well-known carcinogen for a variety of tumors in human and in mouse, and can induce DNA damages in target cells and also disrupt their microenvironment.
Mouse thymic lymphomas are one of the classic models of ionizing radiation-induced malignancies (Kaplan, 1964; Ludwig et al., 1968; Kominami and Niwa, 2006) , and their developmental process may be conformed to the sequential model for mutation accumulation, proposed for the colorectal cancer development (Fearon and Vogelstein, 1990; Kinzler and Vogelstein, 1996) . Whole-body irradiation causes thymic atrophy and depletion of bone marrow (BM) cells, followed by a supply in an improper manner of cells from BM to the thymus. Most of the atrophic thymuses eventually develop lymphomas but some remain apparently unchanged. Thus, atrophic thymus may constitute a microenvironment that allows damaged thymocytes to find a population of proliferating and precancerous cells. Indeed, it was reported that prelymphoma cells develop in atrophic thymus within 2 weeks after irradiation (Muto et al., 1987; Sado et al., 1991) . However, study of genetic changes of thymocytes in the atrophic thymus has not been performed.
We have identified previously two genes, Ikaros and Bcl11b/Rit1/CTIP2, that underwent bi-allelic DNA changes in mouse thymic lymphomas (Okano et al., 1999; Shinbo et al., 1999; Wakabayashi et al., 2003a) . Both genes encode zinc-finger transcription factors that regulate the development of lymphocytes (Georgopoulos et al., 1992; Avram et al., 2000; Wakabayashi et al., 2003b) . Ikaros has a proapoptotic function and its inactivation provides resistance to apoptosis, consistent with a predicted property for loss of tumor suppressor gene (Winandy et al., 1995; Yagi et al., 2002) . In contrast, Bcl11b À/À mice exhibit a reduced cellularity and apoptosis of thymocytes (Wakabayashi et al., 2003b) , and this apoptotic phenotype seems to contradict the fact that Bcl11b being the tumor suppressor. Genetic changes of these two genes were also found in human hematopoietic malignancies (Sun et al., 1999; Bernard et al., 2001; Itoyama et al., 2001; Yagi et al., 2002; MacLeod et al., 2003; Nagel et al., 2003; Bezrookove and van Zelderen-Bhola, 2004; Przybylski et al., 2005) . Studies in other laboratories implicated several genes in the lymphoma development such as Myc, Notch1 and PTEN (Klein, 1979; Graham et al., 1985; Ellisen et al., 1991; Mao et al., 2003; Lin et al., 2006; O'Neil et al., 2006) . On the other hand, mutation frequencies of mostly delineated ras and p53 genes were low in radiogenic thymic lymphomas Brathwaite et al., 1992) .
Atrophic thymus induced by whole-body irradiation may comprise a subpopulation of clonally growing cells. If this is the case, DNA alterations may be detectable in thymocytes of those thymuses. This study has examined changes of the genes listed above in thymuses at various times after g-irradiation. Here we show DNA alterations present in some of atrophic thymuses, and changes at Bcl11b and Myc occur earlier than at Ikaros, Pten and Notch1, suggesting the order of mutations during lymphomagenesis.
Results
Clonal growth of thymocytes in atrophic thymus F 1 hybrids between BALB/c and MSM mice were girradiated, and at 150-250 days after irradiation thymus was isolated from apparently 20 healthy mice. Most thymuses (85%) were atrophic, containing 10 6 -10 7 cells, and some (15%) were hypertrophic, comprising more than 5 Â 10 7 cells. Figure 1a displays an example of flow cytometric analysis of an atrophic thymus, showing the presence of a population of large-sized thymocytes. As overt thymic lymphomas consisted of large-sized lymphocytes (Figure 1a) , this suggested the existence of a population of clonally growing cells. We thus examined clonality of thymocytes with a conventional protocol (Kawamoto et al., 2003) , which determines D-J recombination of the TCRb gene locus using polymerase chain reaction (PCR). Three sets of primers were used, one set for recombination between the Db1 and Jb1 loci, the second for the Db2 and Jb2 loci and the third for the Db1 and Jb2 loci (Figure 1b) . DNA from brain provided only one large band with either Db1-Jb1 or Db2-Jb2 primer sets, reflecting no rearrangement. On the other hand, DNA from normal thymus, containing thymocytes of polyclonal origin, showed several smaller bands resulting from rearrangements between different Db and Jb positions. In contrast, DNA from lymphomas showed only one or a few bands, indicating that lymphoma cells were of monoclonal (one prominent band detected) or oligoclonal origin (a few prominent bands detected). DNA from atrophic thymus showed that 13 of the 17 examined comprised one or few bands, and only four showed a pattern similar to normal thymus (Table 1) . This suggests that a clonally growing population(s) is present in atrophic thymuses at a high frequency (76%).
DNA changes in atrophic thymuses
Existence of a clonally growing cell population(s) in atrophic thymuses raised a possibility that these thymocytes have already progressed to a preleukemic stage with loss of heterozygosity (LOH) of some tumor suppressor gene(s). Hence, we examined LOH at Bcl11b, Ikaros and Pten loci in the atrophic thymuses and lymphomas. Figure 2a shows examples of LOH analysis at Bcl11b and Ikaros, and Figure 2b (left) displays the distribution of lymphomas and atrophic thymuses in different band ratios of the BALB/c and MSM Bcl11b alleles. The MSM/BALB allele ratio was designated with a plus sign when it was >1, and with a minus sign when it was o1. The band ratio in normal tissues Multi-step carcinogenesis in radiogenic lymphomas H Ohi et al ranged from 1.2 to À1.2 (data not shown), and hence LOH was judged as positive when the band ratio was >1.5 or oÀ1.5. Based on this criterion, we estimated that LOH frequency at Bcl11b was 71% in atrophic thymuses and 89% in lymphomas. Similar analysis was performed at Ikaros and Pten. LOH frequency at Ikaros was only 6% in atrophic thymuses and 43% in lymphomas, whereas LOH frequency at Pten was 12% in atrophic thymuses and 35% in lymphomas (Table 1) . Although this study did not examine mutation of remaining alleles of the three genes, frequent inactivation (50%) of the remaining Ikaros allele was reported in g-ray-induced thymes lymphomas (Kakinuma et al., 2002) . No lymphomas showed LOH at p53 (data not shown), consistent with previous reports (Brathwaite et al., 1992; Okano et al., 1999) . It is noteworthy that the LOH frequency at Ikaros markedly differed between atrophic thymuses and lymphomas. Recently, Tsuji et al. (2004) reported frequent intragenic deletion of Notch 1 exon 1 in lymphomas and irradiated thymuses, resulting in the activation of Notch1. Accordingly, we examined Notch 1 deletion with the PCR assay, which detected a DNA fragment resulting from the deletion. The deletion frequencies were 18 and 23% in atrophic thymuses and lymphomas, respectively. Trisomy of chromosome 15 harboring the myc gene was found at an early stage of thymic lymphoma development (McMorrow et al., 1988) . We analysed the trisomy using the PCR assay, which detected a polymorphism between the two parental BALB/c and MSM alleles of myc (Figure 2c ). Figure 2b (right) shows the distribution of lymphomas and atrophic thymuses in different band ratios of the BALB/c and MSM Myc alleles. Trisomy was judged by the BALB/c/MSM band ratio to be >1.2 or oÀ1.2, as the band ratio in normal tissues ranged from 1.2 to À1.2 (data not shown). This judgment may be less accurate than that of Bcl11b LOH, but sufficient to permit the comparison of the frequency between lymphomas and atrophic thymuses. The frequency of trisomy was 35% for atrophic thymuses and 66% for lymphomas (Table 1) .
Accumulation of DNA changes and genetic association
We calculated the number of DNA changes at the five loci, Bcl11b, Ikaros, Pten, Notch1 and Myc, in the 35 individual lymphomas. Lymphomas with the changes in four of the five genes were: five (17%), 3/5 were 13 (37%), 2/5 were 10 (29%), 1/5 was five (14%), and without change was one (2.9%). Interestingly, mutual exclusiveness of DNA changes in individual lymphomas was observed between Pten and Notch1 and also between Ikaros and Pten. No lymphomas had changes in both Pten and Notch1, lymphomas having either of them were 19 (11 for Pten and eight for Notch1), and lymphomas having neither were 16 (w 2 test, Po0.001) (see Supplementary Table S1 ), whereas lymphomas having LOH in both Ikaros and Pten were two, those having either of them were 22 (13 for Ikaros and 9 for Pten), and lymphomas having neither were 11 (P ¼ 0.046). Notch1 and Ikaros, on the other hand, showed association of changes in lymphomas. Lymphomas having changes in both genes were six, those having either of them were 11 (two for Notch1 and nine for Ikaros), and lymphomas having neither were 18 (P ¼ 0.037).
Changes in atrophic thymuses at earlier times As LOH was detected in atrophic thymuses, we next examined atrophic thymuses at earlier times, 30 and 100 days, after the start of fractionated irradiation. Neither lymphomas nor hypertrophic thymus was observed at these stages, although it was reported that precancerous cells already exist at these stages (Muto et al., 1987) . Figure 3a displays examples of flow cytomeric analysis of atrophic thymuses. Some of the 100-day samples comprised large-sized thymocytes together with smallsized ones, but none of the 30-day samples exhibited patterns containing large-sized thymocytes. Figure 3b displays 16 examples of clonality assay and Bcl11b LOH assay in atrophic thymuses 30 days later. Clonally growing population was detected in five of the 16, among which two showed LOH at Bcl11b. Table 1 summarizes these results. The frequency of clonal growth was 24% (12 þ 12%) in the 30-day atrophic thymuses and 62% (38 þ 24%) in the 100-day atrophic thymuses. On the other hand, LOH frequency at Bcl11b was 10 and 35%, respectively (see Figure 2b for distribution in the allele ratios). LOH at Ikaros and Pten was very low in those atrophic thymuses, and intragenic deletion of Notch 1 was not detected, whereas myc trisomy was found in two and 35% of the 30 and (15) 35 (11) 23 (8) 66 (23) Abbreviation: LOH, loss of heterozygosity. Numbers indicate % change-positive samples, and numbers in parentheses are those detected.
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Changes in atrophic thymuses induced in Bcl11b-heterozygous mice Bcl11b þ /À mice developed radiogenic thymic lymphomas at a higher incidence and a shorter latency than those of The MSM/BALB allele ratio is designated with a plus sign when the ratio is >1, and with a minus sign when the ratio of BALB/MSM is more than one. (c) PCR products after digestion with Taq I for Myc. Arrowheads indicate the presence of trisomy.
susceptibility by Bcl11b heterozygosity may influence clonal growth and genetic changes in atrophic thymuses. Thus, we examined atrophic thymuses that were prepared from Bcl11b þ /À mice using the same experimental protocols. Table 2 summarizes the results. The frequency of clonal growth was as high as 55% in the 30-day atrophic thymuses and 97% in the 100-day atrophic thymuses, consistent with a shorter latency of lymphomas in Bcl11b þ /À mice. This suggests that most of the 30-day atrophic thymuses comprise a subpopulation(s) of developing prelymphoma. The frequency of loss of the Bcl11b wild-type allele, resulting in total inactivation of Bcl11b, was 40% in the 30-day atrophic thymuses, 47% in the 100-day atrophic thymuses and intriguingly, as high as 80% in the 150-250 day atrophic thymuses. The frequency of 80% was higher than 54% in lymphomas, suggesting that Bcl11b inactivation contributes to clonal growth but is not sufficient for the lymphoma development. Interestingly, the frequency of LOH at Ikaros was higher than that in Bcl11b þ / þ atrophic thymuses. This may reflect the acceleration of lymphoma development in Bcl11b þ /À atrophic thymuses. The frequency of DNA changes at Pten, Notch 1 or Myc did not markedly differ from that in Bcl11b
mice. These results suggest that Bcl11b heterozygosity accelerates the occurrence of clonal growth of thymocytes when irradiated, accompanying increases in the frequency of DNA alterations at Ikaros in atrophic thymuses, but such increase was not remarkable at the other loci.
Contribution of the pre-TCR receptor signaling to clonal growth We observed D-J recombination of the TCRb gene in atrophic thymuses at a higher frequency than LOH at Bcl11b. Success in the recombination produces a pre-TCR receptor complex on the cell surface that stimulates cell proliferation and survival (Shinkai et al., 1993; Newton et al., 2000; Kabra et al., 2001) . Therefore, signaling through the receptor might be a step on the selection pathway of carcinogenesis. To test this possibility, we produced mice harboring mixed hematopoietic stem cells of unarranged and rearranged TCRb genes and examined whether gene-rearranged cells are preferentially selected in clonally growing cells in atrophic thymus. BM cells were isolated from C57BL/ 10(B10) mice and transgenic C57BL/6(B6) mice expressing the rearranged Vb8.1 T-cell receptor gene (Murphy et al., 1990 ) and the two cell preparations were mixed in (14) 36 (9) Abbreviations: LOH, loss of heterozygosity, KO, knockout. Numbers indicate % change-positive samples, and numbers in parentheses are those detected.
Multi-step carcinogenesis in radiogenic lymphomas H Ohi et al the ratios 1:1, 4:1 and 16:1. An aliquot of those mixed cells was then transferred into irradiated severe-combined immunodeficiency (SCID) mice, and 5 weeks after the transfer, the mice were subjected to a single wholebody irradiation of 2.5 Gy, followed by isolation of the thymus 30 days later. Figure 4a shows PCR analysis of D-J recombination in thymocytes. Thymus of mice receiving cells mixed at 1:1 showed the intense band of transgenic Vb8.1 gene and the unrearranged band. Thymus of 4:1 or 16:1 cells showed developmentally rearranged bands in addition to the transgenic-derived band. Figure 4b shows PCR analysis using a set of primers detecting a polymorphism between B10 and B6 DNA. This experiment included thymus and leukocytes, and also as a control, the two tissues that were obtained from mice receiving wild-type B10 and B6 BM cells were mixed at 1:1. The band ratio of B10 and B6 in the wildtype cell-transferred mice was similar between thymocytes and leukocytes. In contrast, the band ratio markedly differed in the mice that were transferred with wild-type and transgenic BM cells. The band ratio in each of different mixtures (1:1, 4:1 and 16:1) was much lower in thymocytes than in leukocytes. These results indicated a preference of cells expressing the rearranged Vb8.1 T-cell receptor gene to grow in thymus relative to wild-type cells, suggesting that the pre-TCR receptor signaling contributes to clonal growth of thymocytes in irradiated mice.
Discussion
This study has analysed genetic changes at Bcl11b, Ikaros, Pten, Myc and Notch1 in g-ray-induced mouse thymic lymphomas and atrophic thymuses isolated at different times after irradiation. Bcl11b and Myc frequently underwent genetic changes at the early stage during lymphomagenesis, whereas alterations of Ikaros, Pten and Notch1 occurred mostly at the late stage. The stage difference in accumulation of DNA changes suggests the order of mutations and can be conformed to the sequential model, proposed to describe the accumulation of mutations necessary for the colorectal cancer development (Fearon and Vogelstein, 1990) . Furthermore, results lead to an implication of their contribution to lymphomagenesis. Examination for recombination at the TCRb receptor locus demonstrated clonal proliferation and expansion in a fraction of atrophic thymuses even 30 days after irradiation. In the atrophic thymuses of wild-type mice, Bcl11b exhibited the highest LOH frequency at the earliest time, which was followed by Pten and Ikaros. Myc also showed alterations, and Notch1 was the latest among them to accumulate mutation. Of Bcl11b þ /À mice, loss of the wild-type Bcl11b allele was detected at high frequencies (40-80%) in atrophic thymuses and lymphomas, consistent with a tumor-suppressor activity of Bcl11b. These results suggest that Bcl11b changes are the critical and possibly the first mutation in the multistep evolution of thymic lymphomas. Our previous studies showed that a marked phenotype of Bcl11b-deficient thymocytes is prevalence of apoptosis (Wakabayashi et al., 2003b; Inoue et al., 2006) . This apoptosis may be triggered by the strong cell proliferation stimulus of committed thymocytes because hyperplastic or dysplastic cells in precancerous lesions often exhibit apoptosis and accompanying high mitotic index (Bartkova et al., 2005; Gorgoulis et al., 2005) . Consistently, 80% of the 150-250-day atrophic thymuses induced in Bcl11b þ /À mice underwent loss of the wild-type allele and showed clonal growth but did not yet develop lymphomas. Therefore, thymocytes in atrophic thymus may well undergo cell proliferation and apoptosis at the same time through a balancing mechanism between cell division and cell death that is probably controlled by surrounding normal tissues (Hanahan and Weinberg, 2000) .
The pre-TCR receptor on the cell surface is signaling molecules to stimulate thymocyte proliferation and survival (Shinkai et al., 1993; Newton et al., 2000; Kabra et al., 2001) . The p56 LCK tyrosine kinase downstream of the receptor plays a key role in transducing mitogenic signals via cyclin D3 (Mombaerts et al., 1994; Sicinska et al., 2003) , and transgenic mice overexpressing p56
LCK are highly prone to T-cell lymphomas (Abraham et al., 1991) . Interestingly, this signaling is required for Notch-driven leukemogenesis (Sicinska et al., 2003) . We observed D-J recombinations of the TCRb gene in atrophic thymus at a higher frequency than genetic changes at Bcl11b locus. This suggests that this signaling followed by chromosomal rearrangement may lead to not only proliferation of normal thymocytes -228 bp -148 bp Figure 4 Growth reference of thymocytes having rearranged T-cell receptor gene in irradiated thymus. (a) Gel electrophoresis of PCR products using the Db2 and Jb2.6 primer set. DNA was isolated from thymus of the SCID mice at 30 days after irradiation, which had received mixtures of BM cells from C57BL/10(B10) mice and transgenic C57BL/6(B6) mice expressing the Vb8.1 rearranged T-cell receptor gene. The ratio mixed of B10 with B6 is indicated on gel lane. (b) Gel electrophoresis of MboI digests of PCR products that were amplified using a set of primers detecting polymorphism at an MboI cleavage site between B10 and B6 DNA. DNA used was isolated from thymus and peripheral blood leukocytes of the SCID mice described above. Also, this experiment included the two tissues obtained from the SCID mice that had received wild-type B10 and B6 BM cells mixed at 1:1.
Multi-step carcinogenesis in radiogenic lymphomas H Ohi et al but also the expansion of prelymphoma cells in atrophic thymus. Therefore, the pre-TCR receptor signaling can be a key factor to start clonal growth of thymocytes and hence the DNA rearrangement may be one of the first DNA changes contributing to lymphomagenesis. Indeed, our result showed that thymocytes expressing the rearranged Vb8.1 T-cell receptor gene prefer to grow in irradiated thymus relative to wild-type thymocytes. Trisomy of Myc was found in as high as one-third of the 100-day atrophic thymuses. This suggests that Myc trisomy tends to take place at an early time similar to that of Bcl11b inactivation. Increase in Myc expression contributes to cell proliferation, and at the same time, however, triggers apoptosis by increasing the levels of proapoptotic proteins such as p53. Accordingly, transgenic Myc-induced lymphomas exhibit frequent inactivating mutations of p53 or p19ARF (Eischen et al., 1999) .
In contrast to Bcl11b and myc, DNA alterations of Ikaros, Pten and Notch1 occurred mostly at the late stage. LOH frequency at Ikaros was very low in atrophic thymus, though high in thymic lymphomas. Ikaros has a proapoptotic function and inactivation of Ikaros contributes to resistance for apoptosis in vitro (Yagi et al., 2002; Ruiz et al., 2004) . Analysis of the knockout mice also implicates Ikaros in lymphomagenesis (Winandy et al., 1995; Dumortier et al., 2006) . Therefore, it may be reasonable to speculate that Ikaros inactivation rescues prelymphoma cells from the apoptosis provided by Bcl11b inactivation (Wakabayashi et al., 2003b; Inoue et al., 2006) or Myc activation (Eischen et al., 1999) , leading to rapidly progressive tumor phenotype. Likewise, Pten inactivation may provide rescue from apoptosis as shown by in vitro and in vivo studies (Mayo et al., 2002; Freeman et al., 2003) and thereby may confer susceptibility to thymic lymphomas. Mutual exclusiveness of mutations observed between Ikaros and Pten may reflect their common function of conferring apoptosis.
Activating mutations in Notch1 are frequently found in human T-cell leukemias (Weng et al., 2004) and in mouse T-cell lymphomas (Tsuji et al., 2004; Dumortier et al., 2006; Lin et al., 2006; O'Neil et al., 2006) . Our study demonstrated activation of Notch1 by intragenic deletion in some of thymic lymphomas and atrophic thymuses at 150-250 days after irradiation, but not in atrophic thymuses at earlier stages (30-100 days). This suggests that activated Notch1 may contribute only to expansion of late preleukemic cells. Retroviral mutagenesis studies conducted with c-myc transgenic mice showed that a high frequency of T-cell leukemias occurring with shortened latencies had proviral integrations into Notch1, suggesting that c-myc and Notch1 act through independent, complementary pathways to promote pre-T-cell transformation (Girard et al., 1996; Hoemann et al., 2000) . However, preference of Notch1 activation to lymphomas with Myc trisomy was not found in our study. On the other hand, mutual preference of mutations was observed between Notch1 and Ikaros, suggesting that their alterations synergistically contribute to lymphomagenesis. This is consistent with the finding that introduction of Ikaros inhibits the activated Notch1-driven leukemogenesis (Dumortier et al., 2006) . Note that mutual exclusiveness of mutations was observed between Notch1 and Pten, although their relationship is not clear. Altogether, these results suggest genetic association among Ikaros, Pten and Notch1 genes, changes of which contribute to the late stage of lymphomagenesis. Hanahan and Weinberg (2000) depicted the key factors in the transition from a human normal cell to a malignant cancer cell. These are the acquisition of six specific capabilities: independent of external growth signals, insensitivity of anti-growth signals, ability to avoid apoptosis, infinite replication, angiogenesis, and tissue invasion and metastasis. Furthermore, Hahn and Weinberg (2002) described fewer genetic changes in mouse models for the induction of tumors than in comparative tissue sites in humans. Therefore, the mouse thymic lymphomas may be induced without some of the capabilities. These capabilities may be the last three: the mouse has long telomeres and active telomerase capable to replicate adequately, thymic lymphomas are free from necrosis, and the mouse tumors metastasize very rarely. On the other hand, the first three capabilities are probably required during lymphomagenesis. As described above, inactivation of Bcl11b or Myc activation found in atrophic thymuses may render thymocytes independent of external growth stimulation, whereas Ikaros or Pten inactivation may confer ability to avoid apoptosis. It is not clear, however, which gene inactivation overcomes the possible growth-inhibitory signal from the thymic microenvironment. Notch1 and Myc might be the candidates, because expression of these genes is tightly-regulated, such that their expression is highly sensitive to external cellular cues. Notch ligands are expressed on thymic stromal cells and play key roles in proliferation and differentiation of thymocytes during T-cell development (Gray et al., 2005) . Myc activity is also regulated during the transition from an undifferentiated to a differentiated state. A switch from Myc-Max to Mad-Max complexes is known to occur and the Mad-Max complexes then elicit differentiation-inducing signals (Hanahan and Weinberg, 2000; McArthur et al., 2002) . Another possibility is that the insensitivity of anti-growth signals is not required for g-ray-induced thymic lymphomas, because atrophic or disorganized thymus may be a microenvironment incapable to give anti-growth signals.
Our results showed that 31% of the thymic lymphomas underwent DNA changes in two of the five genes (Bcl11b, Ikaros, Myc, Pten and Notch1), 43% underwent in three, and 17% underwent in four. As discussed above, the development of mouse thymic lymphomas may require only two (if the insensitivity of anti-growth signals is not required) or three specific capabilities. If this is the case, these five genes are major targets for mutation, and mutation in two or three of the five is sufficient for genesis of most of the thymic lymphomas. This idea does not ignore the involvement of epigenetic (possibly secondary genetic) changes of many other genes following these mutations.
A small fraction (9%) of lymphomas was free from DNA changes or contained only one of the five genes. This suggests either the presence of as yet identified mutations or epigenetic inactivation of some of the five candidate genes.
Materials and methods

Mice
Bcl11b
þ /À mice of the BALB/c background were generated as described (Wakabayashi et al., 2003b) . TCRb transgenic mice of the C57BL/6 background expressing a rearranged TCRb receptor gene (V 8/D 1/J 1.1 gene; Murphy et al., 1990) were purchased from (Taconic M&B, Hudson, NY, USA) and BALB/c and CB17 SCID mice were from CLEA Japan Inc. (Tokyo, Japan). MSM mice were kindly supplied from Dr Shiroishi (NIG at Mishima, Japan). Mice used in this study were maintained under specific pathogen-free conditions in the animal colony of the Niigata University.
Induction of atrophic thymus and lymphoma development Bcl11b
þ / þ and Bcl11b þ /À BALB/c mice were mated with MSM mice and their progeny were subjected to g-irradiation of 2.5 Gy four times at a weekly interval, starting at the age of 4 weeks. Thymus was isolated at 30, 100 and 150-250 days after the start of irradiation. Development of thymic lymphoma was diagnosed by inspection of labored breathing and palpable induration of thymic tumor. Existence of tumors was confirmed upon autopsy of the mice. Thymic lymphomas composed of approximately 2 Â 10 8 cells and atrophic thymuses at 30 days after irradiation composed of approximately 10 6 cells. Genotyping of Bcl11b alleles was carried out as described previously (Wakabayashi et al., 2003b) . All animal experiments comply with the guidelines by the animal ethics committee for animal experimentation of Niigata University.
Flow cytometry
The cell size of thymocytes was determined on a FACSAria (BD Biosciences, San Jose, CA, USA), and data were analysed using the Flow-Jo software (Tree-Star). Dead cells and debris were excluded by appropriating the gating of forward light scatter and side light scatter.
Stem cell transfer BM cells were isolated from wild-type C57B6(B6) mice, TCRb transgenic B6 mice and wild-type C57B10(B10) mice, and suspended in Eagle's medium supplemented with 5 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid and 2% fetal calf serum. After washing three times with medium, BM cells of wild-type B6 and B10 were mixed at 1:1, and BM cells of transgenic B6 and wild-type B10 were mixed at 1:1, 1:2, 1:4 and 1:16 ratios. An aliquot of cell mixtures (1-2 Â 10 7 cells) was injected into the tail vein of SCID mice. Five weeks after the transfer, the mice were subjected to a single whole-body irradiation of 2.5 Gy, followed by isolation of the thymus and peripheral blood leukocytes 30 days later.
DNA isolation DNA was isolated from brain, lymphomas, thymocytes and peripheral blood leukocytes using the DNeasy Tissue Kit (Qiagen, Valencia, CA, USA).
PCR analysis of D-J recombination in TCRb locus PCR for TCRb rearrangements was performed as described (Kawamoto et al., 2003) . Template DNA was used at three different concentrations in each experiment to ensure linearity of the PCR signal. As a control for the amount of template DNA, aliquots of a PCR mixture were amplified with primers specific for a-catenin (5 0 -GCATGGCTACAGTTACTAATG-3 0 ) and (5 0 -TGAGCCCGATGGTGAATTTG-3 0 ). The reaction was processed through 32 cycles of 941C for 30 s, 631C for 1 min and 721C for 2 min.
PCR analysis of allelic differences, intergenic deletions and gene amplifications PCR was performed as described previously (Wakabayashi et al., 2003a, b) . Primers were: Bcl11b, 5 0 -GGCTGAATTTA CAGGATGAGG and 5 0 -CTTGAACCCCAACTTCTGTG; Ikaros, 5 0 À TGAGAAGCCCTTCAAATGCC and 5 0 À CTG GGAACATGGAACACATG; Myc, 5 0 -GCAGACACTTCT CACTGGAA and 5 0 -GTTTCCAACGCCCAAAGGAA. Primers for Notch1 deletion were 5 0 -GGAATGCCTACTTTG TATGAGG and 5 0 -ATTTCTCCTTTAGGTTCCTTTGAG. Primers to discriminate between C57B6 and C57B10 genomes were 5 0 -GCTACACAAAGAAACTCGCCC and 5 0 -ATGCT GAGAGTACGCAGATGC. PCR products were analysed for SNPs by gel electrophoresis after appropriate restriction enzymes. HinfI digests of Bcl11b products gave 256 and 228 bp for BALB/c and 256, 148 and 83 bp for MSM. HapII digests of Ikaros products gave 88 and 60 bp for BALB/c and 67, 43, 21 and 17 bp for MSM. TaqI digests of Myc products gave 178 bp for BALB/c and 140 and 38 bp for MSM. MboI was used for detection of a SNP between C57B6 and C57B10 genomes, which gave 171 and 32 bp for B6 and 105, 66 and 32 bp for B10. PCR products using Mit markers (D12Mit181 for Bcl11b; D19Mit64 for Pten) were analysed by gel electrophoresis. PCR bands were stained with ethidium bromide and band intensities were quantitated with a Molecular Imager FX (Bio Rad, Hercules, CA, USA). Ratio of BALB/c and MSM alleles or of MSM and BALB/c alleles in lymphomas and atrophic thymus was normalized with that of normal brain DNA. The BALB/c and MSM allele ratio was designated with a plus sign when it was >1, and with a minus sign when it was o1.
